STSGX Mutual Fund
STSGX Mutual Fund
STSGX Mutual Fund
American Beacon Stephens Small Cap Growth Fund Investor Class
STSGX Mutual Fund Overview
STSGX Mutual Fund (American Beacon Stephens Small Cap Growth Fund Investor Class) is managed by American Beacon Funds with $36.8M in net assets. STSGX expense ratio is 1.27%, holding 98 positions across sectors including Information Technology, Health Care, Industrials. Inception date: 2005-12-01.
STSGX performance shows a YTD return of 12.24%. The 1-year return is 11.38% and the 5-year return is 3.75%.
STSGX top holdings include Halozyme Therapeutics Inc (2.0%), Ligand Pharmaceuticals, Inc. (2.0%), Repligen Corp (1.9%), Firstcash Inc (1.9%), Xometry, Inc. (1.9%). Go to all STSGX holdings, STSGX sectors, or STSGX dividends.
STSGX can be compared against other funds. Use STSGX overlap to find shared positions, or STSGX vs another fund for a side-by-side view. STSGX alternatives are available via the screener, along with tax-loss harvesting opportunities.